Back to News
Market Impact: 0.2
SL Science Reports Higher Revenue, Expands Gross Margin In First Half 2026
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
SL Science Holding Limited reported higher revenue and improved gross margins for the first half of 2026, supported by growth in wholesale distribution. The company also increased investment in developing its cell therapy programs; the article provides no financial figures or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- SK Hynix third-quarter profit sharply beats estimates on AI memory boost
- SK Hynix Posts Record Profit Amid AI Rush
- Anthropic's IPO could be 'speculative fiction' or a 'generational moment' — investors are split
- Anthropic Gives Traders a Pure-Play Bet on Frontier AI
- VCs will make billions on Anthropic’s IPO, but Amazon is set to make much (much) more
- Analysis-Hold or sell? High Treasury yields spur US banks to rethink bond portfolios